These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 31112029)

  • 21. Some specificities in the management of hyperglycemia in patients with diabetic kidney disease.
    Dragović T; Marinković D; Kiković S; Pejović J; Hajduković Z
    Vojnosanit Pregl; 2016 Sep; 73(9):857-63. PubMed ID: 29320619
    [No Abstract]   [Full Text] [Related]  

  • 22. The Combined Impact of Chronic Kidney Disease and Diabetes on the Risk of Colorectal Cancer Depends on Sex: A Nationwide Population-Based Study.
    Oh HJ; Lee HA; Moon CM; Ryu DR
    Yonsei Med J; 2020 Jun; 61(6):506-514. PubMed ID: 32469174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of basal insulins in the treatment of people with type 2 diabetes and chronic kidney disease: A narrative review.
    Sloan L; Cheng AYY; Escalada J; Haluzík M; Mauricio D
    Diabetes Obes Metab; 2024 Apr; 26(4):1157-1170. PubMed ID: 38225217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycemic control in diabetic CKD patients: where do we stand?
    Kovesdy CP; Sharma K; Kalantar-Zadeh K
    Am J Kidney Dis; 2008 Oct; 52(4):766-77. PubMed ID: 18572289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimal medication dosing in patients with diabetes mellitus and chronic kidney disease.
    MacCallum L
    Can J Diabetes; 2014 Oct; 38(5):334-43. PubMed ID: 25284697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycemic Control in Patients with Diabetic Kidney Disease; Time to Recognize Perils of Iatrogenic Hypoglycemia?Moving away from Intensive Glycemic Control.
    Gupta P; Gupta R; Gupta AK
    J Assoc Physicians India; 2018 Sep; 66(9):70-75. PubMed ID: 31321935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoglycemia, chronic kidney disease, and diabetes mellitus.
    Alsahli M; Gerich JE
    Mayo Clin Proc; 2014 Nov; 89(11):1564-71. PubMed ID: 25305751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disturbances in Insulin-Glucose Metabolism in Patients With Advanced Renal Disease With and Without Diabetes.
    Rahhal MN; Gharaibeh NE; Rahimi L; Ismail-Beigi F
    J Clin Endocrinol Metab; 2019 Nov; 104(11):4949-4966. PubMed ID: 31162534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A systematic review of the benefits and harms of dipeptidyl peptidase-4 inhibitor for chronic kidney disease.
    Kamiya H
    Hemodial Int; 2017 Jan; 21(1):72-83. PubMed ID: 27436163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Nutritional approach of the patient with diabetes mellitus and chronic kidney disease. A case report].
    Torres Torres B; Izaola Jáuregu O; De Luis Román DA
    Nutr Hosp; 2017 May; 34(Suppl 1):18-37. PubMed ID: 28585854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipid-lowering treatment and inflammatory mediators in diabetes and chronic kidney disease.
    Almquist T; Jacobson SH; Mobarrez F; Näsman P; Hjemdahl P
    Eur J Clin Invest; 2014; 44(3):276-84. PubMed ID: 24720535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple medication (polypharmacy) and chronic kidney disease in patients aged 60 and older: a pharmacoepidemiologic perspective.
    Sutaria A; Liu L; Ahmed Z
    Ther Adv Cardiovasc Dis; 2016 Aug; 10(4):242-50. PubMed ID: 26920372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimating kidney function and use of oral antidiabetic drugs in elderly.
    Douros A; Ebert N; Jakob O; Martus P; Kreutz R; Schaeffner E
    Fundam Clin Pharmacol; 2015 Jun; 29(3):321-8. PubMed ID: 25817734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel approaches to hypoglycemia and burnt-out diabetes in chronic kidney disease.
    Rhee CM; Kalantar-Zadeh K; Tuttle KR
    Curr Opin Nephrol Hypertens; 2022 Jan; 31(1):72-81. PubMed ID: 34750332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
    Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of comorbidities on glycemic control among Colombian adults with diabetes mellitus: a longitudinal approach with real-world data.
    Urina-Jassir M; Herrera-Parra LJ; Hernández Vargas JA; Valbuena-García AM; Acuña-Merchán L; Urina-Triana M
    BMC Endocr Disord; 2021 Jun; 21(1):128. PubMed ID: 34174843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetes mellitus as a cause or comorbidity of chronic kidney disease and its outcomes: the Gonryo study.
    Iwai T; Miyazaki M; Yamada G; Nakayama M; Yamamoto T; Satoh M; Sato H; Ito S
    Clin Exp Nephrol; 2018 Apr; 22(2):328-336. PubMed ID: 28752289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health behaviors and risk factors associated with chronic kidney disease in Korean patients with diabetes: the Fourth Korean National Health and Nutritional Examination Survey.
    Lee SJ; Chung CW
    Asian Nurs Res (Korean Soc Nurs Sci); 2014 Mar; 8(1):8-14. PubMed ID: 25030487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heart Failure in Patients with Diabetes and Chronic Kidney Disease: Challenges and Opportunities.
    Vijay K; Neuen BL; Lerma EV
    Cardiorenal Med; 2022; 12(1):1-10. PubMed ID: 34802000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycemic management in ESRD and earlier stages of CKD.
    Williams ME; Garg R
    Am J Kidney Dis; 2014 Feb; 63(2 Suppl 2):S22-38. PubMed ID: 24461727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.